MedTrace Logo

Diagnostic Strategies in Patients Suspected of Irritable Bowel Syndrome

NCT00659763 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 149

Last updated 2019-03-28

No results posted yet for this study

Summary

The purpose of this study is to determine whether a clinical diagnosis of irritable bowel syndrome based on patient reported symptoms and a few blood tests is safe, and to determine whether a clinical diagnosis is as good for the patient and as economical for the society as a diagnosis based on exclusion of a number of organic diseases by performing a number of blood tests, fecal analyzes and a scopic examination of bowel.

The purpose of the second part of the study is to determine which intestinal parasites the patients have in their bowel and whether these parasites are the cause of the disease.

Conditions

  • Irritable Bowel Syndrome

Interventions

OTHER

Exclusion diagnosis

Patient fulfill ROME III criteria No Alarmsignals Blood tests: FBC,CRP, ALAT, bilirubins, bas.phosphatases, Albumine, TSH, calcium, celiac screening, lactase gene test. 3 consecutive fecal samples for worm, ovaes and parasites Sigmoidoscopy with biopsy

OTHER

Clinical diagnosis

Patient fulfill ROME III criteria No Alarm signals Blood tests: FBC, CRP.

Sponsors & Collaborators

  • Statens Serum Institut

    collaborator OTHER

  • University of Copenhagen

    collaborator OTHER

  • Zealand University Hospital

    lead OTHER

Principal Investigators

  • Anne Line OE Engsbro, MD · Køge Hospital

  • Peter Bytzer, Professor MD · Køge Hospital

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00659763 on ClinicalTrials.gov